Wolfram syndrome
| Wolfram syndrome | |
|---|---|
| Other names | Diabetes insipidus-diabetes mellitus-optic atrophy-deafness syndrome | 
| Photographic image of the eye showing optic atrophy without retinopathy; from Manaviat et al., 2009 | |
| Specialty | Medical genetics, neurology, endocrinology | 
Wolfram syndrome, also called DIDMOAD (diabetes insipidus, diabetes mellitus, optic atrophy, and deafness), is a rare autosomal-recessive genetic disorder that causes childhood-onset diabetes mellitus, optic atrophy, and deafness as well as various other possible disorders including neurodegeneration. Symptoms can start to appear as early as childhood to adult years (2–65 years old). There is a 25% recurrence risk in children.
It was first described in four siblings in 1938 by Dr. Don J. Wolfram, M.D. In 1995, diagnostic criteria were created based on the profiles of 45 patients. The disease affects the central nervous system (especially the brainstem). There are two subtypes – Wolfram Syndrome Type 1 (WFS1) and Wolfram Syndrome Type 2 (WFS2), that are distinguished by their causative gene.
Less than 5,000 people in the US have this disease, with WFS1 being more common than WFS2.